Here's the live share price of Trident Lifeline along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Trident Lifeline has gained 21.21% CAGR. Over the past year, the corresponding return has been -8.71%.
Trident Lifeline’s current P/E of 28.89x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Trident Lifeline | 0.78 | 4.81 | 4.81 | 9.78 | -8.71 | 37.80 | 21.21 |
Sun Pharmaceutical Industries | 0.99 | -1.32 | -4.43 | -5.58 | -13.53 | 22.86 | 25.44 |
Divi's Laboratories | 1.35 | -1.39 | -9.09 | 7.26 | 10.98 | 19.38 | 13.39 |
Cipla | 0.28 | -0.53 | 1.92 | 4.23 | -6.24 | 14.18 | 15.63 |
Torrent Pharmaceuticals | -2.95 | -3.25 | 7.81 | 15.50 | 2.38 | 33.75 | 19.96 |
Dr. Reddy's Laboratories | 1.32 | 3.70 | -2.69 | 13.92 | -1.44 | 17.09 | 7.19 |
Mankind Pharma | -0.83 | 3.97 | 8.45 | 18.23 | 4.55 | 21.72 | 12.52 |
Zydus Lifesciences | -0.29 | 4.77 | 6.12 | 15.71 | -7.35 | 42.05 | 21.62 |
Lupin | 4.71 | 4.15 | 2.02 | 3.02 | -8.93 | 48.04 | 14.81 |
Abbott India | 1.23 | -4.93 | -2.02 | 2.81 | 6.44 | 20.90 | 13.41 |
Alkem Laboratories | 3.35 | 3.02 | 13.21 | 14.40 | -13.33 | 20.01 | 14.29 |
Aurobindo Pharma | 4.59 | 0.18 | -4.54 | -1.88 | -30.10 | 26.95 | 5.60 |
Glenmark Pharmaceuticals | -1.88 | 5.17 | 23.41 | 45.12 | 19.22 | 77.31 | 32.95 |
Laurus Labs | -0.79 | 3.44 | 31.66 | 53.95 | 77.42 | 20.10 | 27.14 |
Biocon | -1.25 | -1.13 | 0.78 | 7.85 | -7.84 | 7.35 | -3.86 |
Anthem Biosciences | 1.45 | 3.75 | 13.75 | 13.75 | 13.75 | 4.39 | 2.61 |
GlaxoSmithKline Pharmaceuticals | -2.60 | -1.60 | -18.46 | 1.95 | -3.00 | 24.23 | 9.16 |
Cohance Lifesciences | -2.90 | 10.08 | -0.45 | -12.87 | -15.54 | 28.96 | 21.52 |
Gland Pharma | 5.31 | 2.52 | 14.26 | 30.13 | 8.35 | -4.11 | 2.12 |
Ipca Laboratories | -0.61 | -5.32 | -3.76 | -0.34 | -10.15 | 14.97 | 3.52 |
Over the last one year, Trident Lifeline has declined 8.71% compared to peers like Sun Pharmaceutical Industries (-13.53%), Divi's Laboratories (10.98%), Cipla (-6.24%). From a 5 year perspective, Trident Lifeline has outperformed peers relative to Sun Pharmaceutical Industries (25.44%) and Divi's Laboratories (13.39%).
Day | SMA | EMA |
---|---|---|
5 | 284.84 | 281.95 |
10 | 284.02 | 282.44 |
20 | 283.5 | 281.62 |
50 | 277.62 | 278.95 |
100 | 272.44 | 276.5 |
200 | 282.01 | 268.99 |
In the latest quarter, Trident Lifeline remained same as its previous close in promoter holding, while DII stake increased to 0.39%, FII holding rose to 7.21%, and public shareholding moved down to 29.35% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
---|---|
Sep 05, 2025, 10:30 PM IST | Trident Lifeline - Reg. 34 (1) Annual Report. |
Sep 05, 2025, 10:26 PM IST | Trident Lifeline - Notice Of 12Th Annual General Meeting Of The Company |
Sep 01, 2025, 11:29 PM IST | Trident Lifeline - Intimation Of Book Closure And Cut-Off Date For 12Th AGM |
Sep 01, 2025, 11:22 PM IST | Trident Lifeline - Announcement under Regulation 30 (LODR)-Change in Directorate |
Sep 01, 2025, 11:17 PM IST | Trident Lifeline - Annual General Meeting Scheduled To Be Held On 27.09.2025 |
Trident Lifeline Ltd. is a Public Limited Listed company incorporated on 09/01/2014 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L51909GJ2014PLC078227 and registration number is 078227. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 67.80 Cr. and Equity Capital is Rs. 11.50 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Trident Lifeline is ₹283.00 as on Sep 16, 2025.
The Trident Lifeline is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Trident Lifeline is ₹325.43 Cr as on Sep 16, 2025.
Today’s highest and lowest price of Trident Lifeline are ₹284.00 and ₹282.00.
The 52-week high/low is the highest and lowest price at which Trident Lifeline stock has traded in the past 52-week or nearly a year. The 52-week high of Trident Lifeline is ₹334.00 and 52-week low of Trident Lifeline is ₹222.00 as on Sep 16, 2025.
The Trident Lifeline has shown returns of 2.17% over the past day, 4.81% for the past month, 4.81% over 3 months, -8.71% over 1 year, 37.8% across 3 years, and 21.21% over 5 years.
P/E ratio of and PB ratio of Trident Lifeline are 28.89 and 5.65 on Sep 16, 2025. While the company gives a dividend yield of 0.00 per annum.